Have you ever used HYDROCODONE COMBINATION PRODUCTS such as VICODIN, LORCET, OR LORTAB?
The first of two Inflexxion surveys has been completed. Please help us reach our goal by completing the second survey!
The Inflexxion research organisation makes an annual donation to help keep the Bluelight community running. Bluelight and Inflexxion have worked collaboratively on research surveys for 5 years now. We have published a paper together in the peer-reviewed journal Substance Use and Misuse. We review Inflexxion's surveys internally before their launch, and this time, we helped pilot the response options for one of the important items in the survey. We are proud of our ongoing collaboration with Inflexxion and we look forward to another successful survey in 2014.
But, we can only do that if you are prepared to contribute. While this decision should be entirely your own, Bluelight recommends you take the time to consider participating.
The first Inflexxion survey has been completed, though we still need your help in completing the second survey!
COMPLETE SURVEY 2: Hydrocodone combination products
This survey is:
- open to all of the Bluelight community, including people who just read our content, regardless of your drug use status
- anonymous - no IP addresses collected, no identifying information asked
- 10-20 minutes long
- approved by a university ethics committee
This survey is collecting information from participants on their use, misuse, and abuse of prescription opioids, with a particular focus on hydrocodone combination products.
Please do not use your browser’s ‘back’ and ‘forward’ buttons to move through the survey. Use the ’next’ button at the bottom of the survey page to advance forward in the survey. You will not be able to go back to previous questions.
We welcome comments on any aspects of these survey below. We will ensure that any concerns are brought to the attention of the Inflexxion research team.
The first of two Inflexxion surveys has been completed. Please help us reach our goal by completing the second survey!
The Inflexxion research organisation makes an annual donation to help keep the Bluelight community running. Bluelight and Inflexxion have worked collaboratively on research surveys for 5 years now. We have published a paper together in the peer-reviewed journal Substance Use and Misuse. We review Inflexxion's surveys internally before their launch, and this time, we helped pilot the response options for one of the important items in the survey. We are proud of our ongoing collaboration with Inflexxion and we look forward to another successful survey in 2014.
But, we can only do that if you are prepared to contribute. While this decision should be entirely your own, Bluelight recommends you take the time to consider participating.
The first Inflexxion survey has been completed, though we still need your help in completing the second survey!
COMPLETE SURVEY 2: Hydrocodone combination products
This survey is:
- open to all of the Bluelight community, including people who just read our content, regardless of your drug use status
- anonymous - no IP addresses collected, no identifying information asked
- 10-20 minutes long
- approved by a university ethics committee
This survey is collecting information from participants on their use, misuse, and abuse of prescription opioids, with a particular focus on hydrocodone combination products.
Please do not use your browser’s ‘back’ and ‘forward’ buttons to move through the survey. Use the ’next’ button at the bottom of the survey page to advance forward in the survey. You will not be able to go back to previous questions.
We welcome comments on any aspects of these survey below. We will ensure that any concerns are brought to the attention of the Inflexxion research team.
Last edited by a moderator: